Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis
Francesco Iovino(University of Campania "Luigi Vanvitelli"), Michele Orditura(University of Campania "Luigi Vanvitelli"), Ferdinando De Vita(University of Campania "Luigi Vanvitelli"), Giuliano Antoniol(Polytechnique Montréal), Simona Parisi(University of Campania "Luigi Vanvitelli"), Gianluca Gatta(University of Campania "Luigi Vanvitelli"), Francesca Carlino(University of Campania "Luigi Vanvitelli"), A. Perrone(University of Campania "Luigi Vanvitelli"), Franca Ferraraccio(University of Campania "Luigi Vanvitelli"), Anna Diana(University of Campania "Luigi Vanvitelli"), Francesca Fisone(University of Campania "Luigi Vanvitelli"), Fortunato Ciardiello(University of Naples Federico II), Federica Zito Marino(University of Campania "Luigi Vanvitelli"), Iacopo Panarese(University of Campania "Luigi Vanvitelli"), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Madhura S. Tathode(University of Campania "Luigi Vanvitelli"), Roberto Ruggiero(University of Campania "Luigi Vanvitelli"), Ludovico Docimo(University of Campania "Luigi Vanvitelli")
Cited by 13
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer
|Journal of Clinical Oncology|2015|795